Cervical cancer incidence can increase despite HPV vaccination

The Lancet Infectious Diseases

Volumn 10, Issue 9, 2010, Pages 594-595

  Harper, Diane M ^a   Nieminen, Pekka ^b   Paavonen, Jorma ^b   Lehtinen, Matti ^c  

^a UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^b HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^c UNIVERSITY OF TAMPERE   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

WART VIRUS VACCINE;

CANCER INCIDENCE; CANCER INVASION; CANCER MORTALITY; CANCER PREVENTION; CANCER REGISTRY; CANCER SCREENING; FINLAND; HIGH RISK POPULATION; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; LETTER; MORBIDITY; PREVALENCE; PRIORITY JOURNAL; UNITED KINGDOM; UTERINE CERVIX CANCER; VACCINATION; WART VIRUS; FEMALE; IMMUNOLOGY; PAPILLOMAVIRUS INFECTION; UTERINE CERVICAL NEOPLASMS;

FEMALE; FINLAND; GREAT BRITAIN; HUMANS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; UTERINE CERVICAL NEOPLASMS; VACCINATION;

EID: 77955874987     PISSN: 14733099     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1473-3099(10)70182-1     Document Type: Letter

References (8)

1. Bauch CT, Li M, Chapman G, Galvani AP Adherence to cervical screening in the era of human papillomavirus vaccination: how low is too low?. Lancet Infect Dis 2010, 10:133-137.
2. Quinn M, Babb P, Jones J, Allen E Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ 1999, 318:904-908.
3. Peto J, Gilham C, Fletcher O, Matthews FE The cervical cancer epidemic that screening has prevented in the UK. Lancet 2004, 364:249-256.
4. Finnish Cancer Registry (accessed Aug 6, 2010). http://www.cancerregistry.fi/tilastot.
5. Finnish Cancer Registry (accessed Aug 6, 2010). http://www.cancerregistry.fi/joukkltarkastus.
6. Engeland A, Haldorsen T, Tretli S, et al. Prediction of cancer mortality in the Nordic countries up to the years 2000 and 2010, on the basis of relative survival analysis-a collaborative study of the five Nordic Cancer Registries. APMIS Suppl 1995, 49:1-161.
7. Laukkanen P, Koskela P, Pukkala E, et al. Time trends in incidence and prevalence of human papillomavirus type 6, 11 and 16 infections in Finland. J Gen Virol 2003, 84:2105-2109.
8. Lehtinen M, French K, Dillner J, Paavonen J, Garnett G Sound implementation of human papillomavirus vaccination as a community-randomized trial (accessed Aug 6, 2010). http://rokotiitus.uta.fi/english/Lehtinen_proofed-1.pdf.